 This is the VOA Special English Health Report. Malaria control efforts currently depend on things like chemically-treated bed nets and spraying against mosquitoes. But scientists keep trying to find other ways to prevent the disease. A number of vaccines remain under development. Most contain genetically engineered versions of a few proteins from the Plasmodium parasite. Plasmodium is the organism that causes malaria. These modified proteins are designed to get the body's defenses to launch an immune response against the Plasmodium. But the parasite contains thousands of proteins. Another experimental vaccine includes a deactivated version of the entire parasite. Robert Cedar is a researcher at the National Institute of Allergy and Infectious Diseases near Washington. So instead of picking out one or two or three genes, you have the potential for what we call breath, generating an immune response that would be broad rather than narrower. Radiation is used to weaken the parasite so it cannot make people sick or get spread by a mosquito. To make the vaccine, scientists use the parasite at a time in its growth when the organism is called esporozoite. The idea has been known since the 1960s. But Mr. Cedar says a discovery by a researcher at a vaccine company cleared the way for progress. The major breakthrough here was that my collaborator, Stephen Hoffman, at Scenaria, developed a method where he could isolate the esporozoites and purify them so that they could administer it as a vaccine to humans. And no one thought that that was possible. But no one knew either if the weakened esporozoites would activate the immune system to protect against malaria. So researchers tested it on volunteers and found that it was safe. But it was not very effective. Only two out of 44 volunteers were protected when bitten by malaria-infected mosquitoes. To find out why, the researchers tested the vaccine on laboratory animals. They decided that the problem was the way the vaccine had been given to the volunteers. It was injected into the skin to simulate the bite of a mosquito. Mr. Cedar says it would have been more effective if it had been given directly into the blood. However, vaccines are generally given by mouth or injected into the skin or muscle. Having to inject it into the blood could make vaccination programs more difficult if the vaccine is approved for general use. For now, more testing is needed. A report on the testing appeared in the journal Science. For VOA Special English, I'm Carolyn Presuti.